Access our full library of guidance, white papers, and other resources developed by and for the medical technology industry.
AdvaMed® periodically compiles benchmarking data on Member companies’ compliance policies regarding travel and lodging for U.S. Health Care Professionals to assist companies in understanding industry trends and practices when the…
AdvaMed® periodically compiles benchmarking data and developed a survey focused on Member company compliance policies on social media use to assist companies in understanding industry trends and practices when the…
AdvaMed® periodically compiles benchmarking data on Member companies’ use of Health Care Professional (HCP) Interaction Tools to assist companies in understanding industry trends and practices when the information is not…
AdvaMed® periodically compiles benchmarking data on Member companies’ healthcare compliance functions, including department size, budget allocation, and areas of responsibility to assist companies in understanding industry trends and practices when…
AdvaMed® periodically compiles benchmarking data on Member companies’ policies regarding the management of Global Third-Party Intermediaries, including distributors, wholesalers, sales agents, marketing consultants, brokers, and commission agents to assist companies…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Domestic manufacturing EO, federal reforms, and critical RFIs signal changes for MedTech—member input still welcome.
AdvaMed® periodically compiles benchmarking data on Member companies’ policies regarding the provision of meals and refreshments to U.S. Health Care Professionals to assist companies in understanding industry trends and practices…
AdvaMed® periodically compiles benchmarking data on Member companies’ compliance policies regarding Educational Grants to assist companies in understanding industry trends and practices when the information is not competitively sensitive.
No FDA overhaul, new federal procurement EOs, and a major court case could shift preventive care coverage requirements.